Rubric Capital Management 13F holdings, Q1 2024
Holdings as of March 31, 2024 · filings on SEC EDGAR · latest filing →
Rubric Capital Management disclosed 68 US equity positions worth $3.4bn in its Q1 2024 13F filing. The largest position was TEVA at 7.4% of the reported book, followed by VTRS and ROIV. Against the Q4 2023 filing, it opened 9 new positions, added to 20 and reduced 12 among the top 50 holdings.
What did Rubric Capital Management own in Q1 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2023 |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 7.4% | $249.3m | 17,669,588 | -3% | reduced |
| 2 | VTRS VIATRIS INC | Healthcare | 6.5% | $220.2m | 18,442,093 | 5% | added |
| 3 | ROIV ROIVANT SCIENCES LTD | Healthcare | 6.2% | $210.8m | 20,000,000 | 5% | added |
| 4 | GLNG GOLAR LNG LTD | Energy | 4.6% | $156.6m | 6,506,757 | 0% | held |
| 5 | BGC BGC GROUP INC | Financial Services | 4.4% | $147.6m | 19,000,000 | -5% | reduced |
| 6 | 07WA MR COOPER GROUP INC | 3.5% | $118.4m | 1,518,773 | -15% | reduced | |
| 7 | QDEL QUIDELORTHO CORP | Healthcare | 3.4% | $115.1m | 2,400,000 | 145% | added |
| 8 | FLR FLUOR CORP NEW | Industrials | 3.2% | $109.9m | 2,600,000 | 72% | added |
| 9 | VST VISTRA CORP | Utilities | 2.5% | $84.6m | 1,213,998 | – | new |
| 10 | CSTM CONSTELLIUM SE | Basic Materials | 2.4% | $80.3m | 3,630,347 | 24% | added |
| 11 | PACTIV EVERGREEN INC | 2.3% | $79.4m | 5,541,393 | 10% | added | |
| 12 | MATV MATIV HOLDINGS INC | Basic Materials | 2.2% | $75.0m | 4,000,000 | 49% | added |
| 13 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 2.2% | $74.4m | 7,510,000 | 13% | added |
| 14 | HRTX HERON THERAPEUTICS INC | Healthcare | 2.2% | $74.0m | 26,713,503 | 0% | held |
| 15 | COLL COLLEGIUM PHARMACEUTICAL INC | Healthcare | 2.1% | $71.2m | 1,834,027 | -34% | reduced |
| 16 | RENEW ENERGY GLOBAL PLC | 2.1% | $70.3m | 11,711,700 | 12% | added | |
| 17 | IBIT ISHARES BITCOIN TR | 2.1% | $69.7m | 1,722,497 | – | new | |
| 18 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 2.0% | $66.3m | 958,533 | -15% | reduced |
| 19 | LIBERTY GLOBAL LTD | 1.9% | $65.1m | 3,845,351 | 29% | added | |
| 20 | DOLE DOLE PLC | Consumer Defensive | 1.8% | $61.3m | 5,141,388 | 13% | added |
| 21 | SSYS STRATASYS LTD | Technology | 1.7% | $58.7m | 5,050,000 | 19% | added |
| 22 | AMRX AMNEAL PHARMACEUTICALS INC | Healthcare | 1.7% | $57.8m | 9,541,948 | 19% | added |
| 23 | VYX NCR VOYIX CORPORATION | Technology | 1.7% | $57.4m | 4,546,081 | 27% | added |
| 24 | OFIX ORTHOFIX MED INC | Healthcare | 1.6% | $53.2m | 3,665,000 | 0% | held |
| 25 | ADEA ADEIA INC | Technology | 1.5% | $50.7m | 4,640,009 | 0% | held |
| 26 | XPER XPERI INC | Technology | 1.4% | $48.8m | 4,043,744 | 58% | added |
| 27 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 1.3% | $44.7m | 13,552,997 | 0% | held |
| 28 | AIR AAR CORP | Industrials | 1.3% | $43.4m | 725,000 | -19% | reduced |
| 29 | KINIKSA PHARMACEUTICALS LTD | 1.3% | $43.3m | 2,196,009 | -24% | reduced | |
| 30 | PLAYA HOTELS & RESORTS NV | 1.2% | $40.3m | 4,155,840 | -6% | reduced | |
| 31 | EXTR EXTREME NETWORKS | Technology | 1.2% | $39.8m | 3,450,000 | – | new |
| 32 | PLAY DAVE & BUSTERS ENTMT INC | Communication Services | 1.1% | $37.5m | 598,503 | – | new |
| 33 | ZYME ZYMEWORKS INC | Healthcare | 1.1% | $36.6m | 3,475,384 | 0% | held |
| 34 | ATMU ATMUS FILTRATION TECHNOLOGIE | Consumer Cyclical | 1.1% | $36.5m | 1,132,056 | – | new |
| 35 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 1.0% | $33.7m | 10,500,000 | 267% | added |
| 36 | LIBERTY GLOBAL LTD | 1.0% | $33.4m | 1,893,293 | 2% | added | |
| 37 | KOP KOPPERS HOLDINGS INC | Basic Materials | 0.9% | $31.6m | 572,658 | -43% | reduced |
| 38 | TAC TRANSALTA CORP | Utilities | 0.9% | $30.1m | 4,687,158 | -9% | reduced |
| 39 | PARR PAR PAC HOLDINGS INC | Energy | 0.8% | $28.6m | 772,384 | -36% | reduced |
| 40 | CNNE CANNAE HLDGS INC | Consumer Cyclical | 0.8% | $27.0m | 1,214,217 | 235% | added |
| 41 | SDGR SCHRODINGER INC | Healthcare | 0.8% | $27.0m | 998,276 | – | new |
| 42 | CAR AVIS BUDGET GROUP | Industrials | 0.8% | $26.3m | 215,092 | – | new |
| 43 | CHRS COHERUS BIOSCIENCES INC | Healthcare | 0.7% | $24.9m | 10,400,000 | 2532% | added |
| 44 | RSKD RISKIFIED LTD | Technology | 0.7% | $22.6m | 4,173,636 | 0% | held |
| 45 | SPRINGWORKS THERAPEUTICS INC | 0.6% | $21.0m | 426,768 | – | new | |
| 46 | FIP FTAI INFRASTRUCTURE INC | 0.6% | $20.1m | 3,193,530 | 0% | held | |
| 47 | NUVALENT INC | 0.6% | $19.7m | 261,874 | – | new | |
| 48 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.6% | $19.2m | 5,564,123 | -2% | reduced |
| 49 | SCPHARMACEUTICALS INC | 0.5% | $17.7m | 3,525,000 | 1% | added | |
| 50 | OVID OVID THERAPEUTICS INC | Healthcare | 0.5% | $16.2m | 5,315,969 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.